Condition (MeSH)
Hutchinson's Melanotic Freckle
ClinicalTrials.gov lists 12 trials for Hutchinson's Melanotic Freckle or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
12 of the 12 trials are tagged with Hutchinson's Melanotic Freckle itself; the rest are tagged with a narrower condition beneath it.
When did Hutchinson's Melanotic Freckle trials start? (10)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2023 | 1 |
| 2022 | 1 |
| 2019 | 1 |
| 2017 | 1 |
| 2016 | 2 |
| 2015 | 2 |
| 2011 | 1 |
| 2010 | 1 |
| 2008 | 1 |
| 2005 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 12 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Hutchinson's Melanotic Freckle trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 2/3 | 1 |
| Phase 3 | 1 |
| Phase 4 | 2 |
| Not applicable | 3 |
| Observational | 4 |
How many Hutchinson's Melanotic Freckle trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Active, not recruiting | 1 |
| Completed | 8 |
| Terminated | 1 |
| Withdrawn | 1 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Hutchinson's Melanotic Freckle trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Lucid, Inc. | 1 |
| Skin Care Network Ltd. | 1 |
Interventions as named in the registry (6)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Imiquimod 5% | 3 |
| 5-aminolevulinic acid nanoemulsion | 1 |
| Tazarotene Cream 0.1% | 1 |
| IMIQUIMOD cream | 1 |
| Picato gel | 1 |
Showing 5 of 6 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Hutchinson's Melanotic Freckle? (11)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Reflectance confocal microscopy to diagnose malignant melanoma and lentigo maligna in the UK: a single-centre prospective observational trial. | The British journal of dermatology | 2024 | Yes |
| Ingenol mebutate to treat lentigo maligna of the head (face and scalp): A prospective, multicenter, single-arm phase 2 trial indicates no benefit. | Journal of the American Academy of Dermatology | 2020 | Yes |
| Development of a Pigmented Facial Lesion Scale Based on Darkness and Extent of Lesions in Older Veterans. | The Journal of investigative dermatology | 2019 | Yes |
| A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions. | Archives of dermatology | 2012 | Yes |
| Porcine xenograft biosynthetic wound dressings for the management of postoperative Mohs wounds. | Dermatology online journal | 2011 | Yes |
Showing 5 of 11 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.